diabetes header graphic


The Amazing Health Benefits Of Omega-3 Fats
By Robert Spadinger
Omega 3 fats got quite a lot of media coverage in recent years and I'm sure you already read or heard on or the other story about them. But the question is, can they really deliver what they promise? Are omega 3 fats some kind of miracle medicine or is all just media hype?

Actually, none of both is true. Please don't expect omega 3's to be a universal cure for each and every ailment. On the other hand, it's not all hype neither. There actually is overwhelming scientific proof for the numerous health benefits of omega 3 fatty acids and we will talk about them in a minute.

But first, what are omega 3 fats anyway?

Omega 3 fatty acids belong to the group of essential fats, which means they cannot be produced by the body and have to be provided from external sources.

There are actually 3 important types of omega 3 fats:

* Alpha-linolenic acid (ALA)
* Eicosapentaenoic acid (EPA)
* Docosahexaenoic acid (DHA)

ALA can be obtained from the following sources: Flaxseed oil, walnuts, pumpkin seeds, green leafy vegetables and others. The richest source of EPA and DHA is fatty fish, such as salmon, mackerel, herring and sardines.

The body converts ALA into EPA and DHA. However, older people and people suffering from or schizophrenia may lack the ability to convert ALA into EPA and DHA. In these cases it's more advisable to obtain omega 3 fatty acids from sources that are rich in EPA and DHA.

As I already mentioned, the best source of EPA and DHA is fatty fish, but you can also take omega 3 fish oil supplements if you don't like the taste of fish or if you need increased amounts of omega 3 fatty acids.

The numerous health benefits of omega 3's

It all started back in the 70's, when researchers discovered that Eskimos showed a surprisingly low rate of cardiovascular diseases although they had a very fat-rich diet due to their high consumption of fish.

The common logic was: Eskimos are overweight and their should be more incidences of heart disease, but there were not. Why? Scientists concluded that it must be because of their diet, which is very rich in omega 3 fatty acids.

Over

Efficacy of Adding Sitagliptin or Pioglitazone to T2DM Insufficiently Controlled With Metformin and Sulfonylurea
<b>Condition</b>:   Type 2 Diabetes<br/><b>Interventions</b>:   Drug: Sitagliptin;   Drug: pioglitazone<br/><b>Sponsor</b>:   Mackay Memorial Hospital<br/><b>Recruiting</b> - verified September 2010
Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: HUMAN INSULIN (BIOSYNTHETIC);   Drug: Insuplant<br/><b>Sponsor</b>:   Sanofi-Aventis<br/><b>Not yet recruiting</b> - verified September 2010
Efficacy and Safety of Linagliptin (BI 1356) in Black/African Americans With Type 2 Diabetes With a MTT Sub-study
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Placebo;   Drug: Linagliptin<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified September 2010
Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Drug: Formoterol<br/><b>Sponsors</b>:   Yale University;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified September 2010
Insulin Administration Plus a Telemedicine System (Diabetes Interactive Diary - DID) vs Insulin Plus Common Practice
<b>Condition</b>:   Type 1 Diabetes<br/><b>Intervention</b>:   Device: Diabetes Interactive Diary (DID)<br/><b>Sponsors</b>:   Consorzio Mario Negri Sud;   Sanofi-Aventis;   LifeScan<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type II<br/><b>Intervention</b>:   Drug: Insulin LISPRO<br/><b>Sponsor</b>:   Halozyme Therapeutics<br/><b>Recruiting</b> - verified September 2010
Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes: An Extension Trial to NN1250-3579
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With or Without Metformin and With/Without Pioglitazone in Type 2 Diabetes: An Extension Trial to NN1250-3582
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin glargine;   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
BI 10773 Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: BI 10773;   Drug: Placebo<br/><b>Sponsor</b>:   Boehringer Ingelheim Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Bristol-Myers Squibb;   AstraZeneca<br/><b>Active, not recruiting</b> - verified August 2010
A Study of OPC-262 in Patients With Type 2 Diabetes
<b>Condition</b>:   Diabetes, Type 2<br/><b>Intervention</b>:   Drug: OPC-262<br/><b>Sponsor</b>:   Otsuka Pharmaceutical Co., Ltd.<br/><b>Recruiting</b> - verified August 2010
Glycemic Holter Study (Continuous Glucose Monitoring) -
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: Vildagliptin;   Drug: Sitagliptin<br/><b>Sponsor</b>:   Novartis<br/><b>Recruiting</b> - verified August 2010
Psychosocial Interventions in the Treatment of Youth With Type 1 Diabetes Mellitus
<b>Condition</b>:   Diabetes Mellitus<br/><b>Intervention</b>:   Behavioral: psychosocial intervention<br/><b>Sponsor</b>:   Assaf-Harofeh Medical Center<br/><b>Recruiting</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin XR Tablet (Manufactured in Mt Vernon, IN) Relative to 5 mg Saxagliptin Tablet and 500 mg Metformin XR Tablet (Manufactured in Evansville, IN)
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: metformin XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
Bioequivalence Study of the Fixed Dose Combination of 5 mg Saxagliptin/1000 mg Metformin XR (Manufactured in Mt Vernon, IN) Relative to 5 mg of Onglyza and 2 × 500 mg Glucophage XR
<b>Condition</b>:   Diabetes Mellitus<br/><b>Interventions</b>:   Drug: saxagliptin;   Drug: Glucophage XR;   Drug: saxagliptin + metformin XR (FDC tablet)<br/><b>Sponsor</b>:   Bristol-Myers Squibb<br/><b>Completed</b> - verified August 2010
A Study in Patients With Type 2 Diabetes Mellitus (AWARD-4)
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Drug: Insulin Glargine;   Drug: LY2189266<br/><b>Sponsor</b>:   Eli Lilly and Company<br/><b>Not yet recruiting</b> - verified August 2010
Comparison of NN1250 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes: An Extension Trial to NN1250-3585
<b>Condition</b>:   Diabetes Mellitus, Type 1<br/><b>Interventions</b>:   Drug: NN1250;   Drug: insulin detemir (Levemir®);   Drug: insulin aspart<br/><b>Sponsor</b>:   Novo Nordisk<br/><b>Not yet recruiting</b> - verified August 2010
Exploratory Study to Evaluate the Efficacy of Androxal in Controlling Blood Glucose in Men With Type-2 Diabetes Mellitus and Secondary Hypogonadism or Adult-Onset Idiopathic Hypogonadotropic Hypogonadism
<b>Conditions</b>:   Type 2 Diabetes Mellitus;   Secondary Hypogonadism<br/><b>Interventions</b>:   Drug: Placebo;   Drug: enclomiphene citrate<br/><b>Sponsor</b>:   Repros Therapeutics Inc.<br/><b>Not yet recruiting</b> - verified August 2010
Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes
<b>Condition</b>:   Type 1 Diabetes Mellitus<br/><b>Intervention</b>:   Drug: teplizumab or placebo<br/><b>Sponsors</b>:   MacroGenics;   Eli Lilly and Company<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus (0431-251)
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: sitagliptin phosphate;   Drug: Glimepiride<br/><b>Sponsor</b>:   Merck<br/><b>Not yet recruiting</b> - verified August 2010
Four-Hour Evaluation of a Medical Food in Subjects With Type 2 Diabetes
<b>Condition</b>:   Diabetes Mellitus, Type 2<br/><b>Interventions</b>:   Other: Experimental nutritional formula #M979;   Other: Standard food<br/><b>Sponsor</b>:   Abbott Nutrition<br/><b>Completed</b> - verified July 2010
Modulation of Free Fatty Acids in Heart Failure Patients With Diabetes: "Effect on Left Ventricular Function"
<b>Conditions</b>:   Heart Failure;   Diabetes<br/><b>Interventions</b>:   Other: Metabolic substrate modulation;   Other: metabolic substrate modulation<br/><b>Sponsors</b>:   University of Aarhus;   Danish Heart Foundation<br/><b>Recruiting</b> - verified August 2010
Study of Two Oral Formulations of LX4211 in Patients With Type 2 Diabetes Mellitus
<b>Condition</b>:   Type 2 Diabetes Mellitus<br/><b>Interventions</b>:   Drug: 300 mg LX4211 (150 mg tablets);   Drug: 300 mg LX4211 (50 mg tablets);   Drug: 300 mg LX4211 (liquid)<br/><b>Sponsor</b>:   Lexicon Pharmaceuticals<br/><b>Not yet recruiting</b> - verified August 2010
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
<b>Conditions</b>:   Androgen Deficiency (AD);   Erectile Dysfunction (ED);   Development of Predictive Cardiovascular/Cerebrovascular AE<br/><b>Intervention</b>:   <br/><b>Sponsors</b>:   Mount Sinai School of Medicine;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)<br/><b>Recruiting</b> - verified August 2010
A Multi-professional Team Intervention on Physical Activity Referrals in Primary Care Patients With Cardiovascular Risk Factors?the Dalby Lifestyle Intervention Cohort (DALICO) Study
<b>Condition</b>:   Motivation for Physical Activity<br/><b>Interventions</b>:   Behavioral: Multi-professional team intervention with PAR, lifestyle brochure;   Behavioral: Ordinary recommendations on health behaviours, lifestyle brochure<br/><b>Sponsors</b>:   Region Skane;   Swedish Council for Working Life and Social Research<br/><b>Not yet recruiting</b> - verified August 2010
Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes
<b>Conditions</b>:   Overweight;   Obesity;   Type 2 Diabetes<br/><b>Interventions</b>:   Behavioral: Caloric restriction;   Behavioral: Diet intervention and structured exercise training program<br/><b>Sponsor</b>:   Institut de Recherches Cliniques de Montreal<br/><b>Not yet recruiting</b> - verified August 2010
A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Diabetic and Hypertensive Filipinos
<b>Condition</b>:   Hypertension<br/><b>Intervention</b>:   Drug: Bisoprolole<br/><b>Sponsor</b>:   Merck KGaA<br/><b>Recruiting</b> - verified August 2010
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
<b>Condition</b>:   Arterial Hypertension<br/><b>Interventions</b>:   Drug: Chlorthalidone 25 mg + amiloride hydrochloride 5 mg;   Drug: Higroton® Laboratório Novartis<br/><b>Sponsor</b>:   Eurofarma Laboratorios Ltda<br/><b>Not yet recruiting</b> - verified August 2010
n-3 Polyunsaturated Fatty Acids (PUFA) Supplementation in Young Women With Polycystic Ovary Syndrome (PCOS)
<b>Condition</b>:   Polycystic Ovary Syndrome<br/><b>Intervention</b>:   Dietary Supplement: LC n-3 PUFA (fish oil) Supplement<br/><b>Sponsors</b>:   The Adelaide and Meath Hospital;   University College Dublin<br/><b>Completed</b> - verified July 2008


the years, these initial assumptions have been confirmed by thousands of studies carried out all over the world. And not only did they confirm the positive effects of omega 3's on cardiovascular diseases, they also discovered numerous other health benefits.

Today we know that Omega 3 fatty acids can help to prevent- and reduce the risk of numerous diseases and that they may also beneficial in the treatment of these diseases.

Here is a list of some of these health benefits provided by omega 3 fatty acids:

* Omega 3's tend to lower cholesterol levels.
* They help to reduce the risk of cardiovascular diseases.
* They help to control high blood pressure.
* Omega-3 fatty acids seem to limit the inflammatory reaction associated with lupus.
* They also help to control constipation, hemorrhoids and diverticular disorders.
* Omega 3 fats may even help to reduce the risk of certain types of cancer, like breast-, colon-, and prostate cancer.
* Omega 3's proofed to be beneficial for the brain development.
* They lower the risk of depression and showed positive effects in the treatment of patients suffering from depression.
* Omega 3 appears to lowers the risk of Alzheimer's disease.
* Omega 3 might be used as a possible treatment for patients with bipolar disorder or schizophrenia.
* Studies also found that EPA might prevent the development of asthma.
* Research points out that omega 3's might reverse atherosclerosis.
* Omega 3 fats proved to be beneficial for people suffering from rheumatoid arthritis.

This is quite an impressive list and it should motivate you to increase your intake of healthy omega 3's if your current diet lacks them. The recommended daily dosages of EPA and DHA is ~ 650 mg and you can obtain these amounts either with a balanced diet containing some of the nutrients I mentioned above, or by supplementing your diet with omega 3 fish oil capsules.

If you suffer from any of the conditions described above, I strongly recommend you get professional advice from a physician. Your doctor knows best what kind of medication you need and if taking omega 3 supplements would be beneficial in your case.

Article Source: http://www.ArticleJoe.com

Omega-3 Health Benefits - Tons of great tips and resources on everything around omega 3. Find out about the health benefits of omega-3, how you can loose weight with omega-3, which foods are rich in omega-3 and much more.




Here are some more diabetes articles...

How To Beat Metabolic Syndrome
By Juliet
Acute pancreatitis is a rapidly-onset inflammation of the pancreas. Pancreatitis is an inflammation of the pancreas. The pancreas is a long gland, located behind the stomach, that secretes Read more...
The Health Benefits Of Juicing
By Nehemiah Maxwell
I started juicing raw vegetables and apples in 1996. It is very easy to do. All you need is a good juicer. Much of the foods people eat, such as french fries, fried chicken, microwave Read more...

Could you have diabetic kidney disease and not even know it?
Questions to ask your doctor.

]]>
Diabetes is the leading cause of chronic kidney disease

Chronic kidney disease (CKD) is on the rise in part because diabetes is on the rise. If you are at risk for diabetes or have been recently diagnosed with the disease, here’s what you should know about the link between diabetes and CKD.

]]>

Diabetes and minorities: What are the risks?
Some ethnic groups develop diabetes at two to six times the rate of whites. If you are African American, Hispanic, Native American, Asian or Pacific Islander, here’s what you should know about your risk for diabetes.

]]>

Preventing chronic kidney disease when you have diabetes

Diabetes is the leading cause of chronic kidney disease. Keeping diabetes in check and early diagnosis of kidney disease could help decrease the chances of developing kidney failure.

]]>

Diet tips for diabetics with kidney disease
When diabetes leads to kidney disease the goal is to preserve kidney function as long as possible and manage diabetes. What you eat can affect both your blood sugar and your kidney function. A dietitian will work with you to create an eating plan that's right for you, probably using some of the diet tips presented here.

]]>

Introduction

Diabetes: definition, causes and symptoms

For a while now, a?leading topic in the United States has been?about the growing number of people?diagnosed with diabetes. But what exactly is diabetes? Here you'll find the definition, causes and signs of diabetes.

]]>

Controlling diabetes
Diabetes is the leading cause of chronic kidney disease in the United States. By controlling diabetes through lifestyle choices such as diet and exercise, taking prescribed medicines and seeing a doctor regularly, people with diabetes can usually maintain a healthy lifestyle and help prevent chronic kidney disease and kidney failure. Find out what you can do to control diabetes.

]]>

Diabetes and chronic kidney disease
Diabetes and chronic kidney disease

Diabetes is the leading cause of chronic kidney disease in America. Many people with diabetes are not aware that chronic kidney disease can lead to kidney failure. However, having diabetes does not necessarily mean you will have kidney failure. Learn about the diabetes and kidney disease connection and how you can keep your kidneys healthy.

]]>

Preventing diabetic kidney disease
All about diabetes Preventing diabetic kidney disease How can I slow the progression of kidney disease? Keeping healthy is the most important part of delaying kidney disease. If you have diabetes and have been diagnosed with an early stage of chronic kidney disease, following your doctor?s instructions regard

]]>

Get the facts

Are you in control of your diabetes?
If you have diabetes, your doctor advises you to keep your glucose levels in a healthy range. One of the problems that can occur for diabetics who don’t control their diabetes is the risk of kidney disease which may lead to kidney failure and dialysis. Diabetes is the leading cause of kidney disease in America. Learn how you can control your diabetes to avoid other health complications such as renal disease.

]]>

Diabetic nephropathy
Image: Diabetic nephropathy

Diabetic nephropathy means kidney damage that occurs as a result of diabetes. Researchers believe poor control of blood sugar or blood glucose levels is one of the reasons people with diabetes develop this type of kidney disease. Learn about diabetic nephropathy symptoms, diagnosis and treatment.

 

 

]]>

Diabetes and peritoneal dialysis
diabetes and pd 340x160Diabetes mellitus is the number one cause of kidney failure in the United States, leading many people to need dialysis. Learn about the relationship between diabetes and chronic kidney disease (CKD), as well as how people with diabetes can choose to do the home dialysis treatment, peritoneal dialysis (PD).

]]>

diabetes and pd

diabetes and pd 340x160

diabetes-definition-causes-and-symptoms

diabetes_definition_causes_and_symptoms